Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

STH Biotech


4, rue Pierre Fontaine – Campus 3
91058 Evry-Courcouronnes Cedex – FRance
Email : h.mailhac@sth-biotech.com

CEO: Héloïse MAILHAC
CTO: Naomi KAMINSKY
Web Site >
STH Biotech - Genopole's company STH Biotech - Genopole's company

Shaker#Industrial Biotech #Biomanufacturing

  • Plant-based biotechnologies
  • BoosterActive compounds
  • Cannabis
  • Pharmaceutics

 

Field of Activity


Via plant biotechnologies, STH BIOTECH reveals the potential of the active compounds of cannabis.

BACKGROUND
Founded by two engineers, both graduates of Sup’Biotech and furthermore laureates of the seventh Shaker class in 2020 and the first Gene.IO class in November 2021.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
STH develops innovative ingredients using a reliable and sustainable plant-production system. Our platform will be able to produce its first dermo-cosmetic ingredient with improved anti-inflammatory properties by 2024. The company will focus thereafter on pharmaceutical cannabinoids.

ACCOMPLISHMENTS / PARTNERSHIPS / HIGHLIGHTS
STH BIOTECH obtained a grant from Bourse French Tech Emergence to finance its research program and benefits also from the Bpifrance Deeptech program.

PARTNERSHIPS SOUGHT
Co-development partnerships
Financing

  • More information

    Strengths:
    Expertise in cannabis, strategic partnerships

    Innovation assets:
    Plant-based biotechnology, performance, standardization, environmental impact.

Share
Genopole’s Companies

#Industrial Biotech


In the same field

The VERY Food Co

Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.

Discover
Synovance - entreprise généopolitaine

Synovance

Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Discover
FABMID - entreprise génopolitaine

FABMID

We develop an in vitro manufactured targeted DNA vector to improve the efficiency of therapeutic cell transfection and to reduce the cost of gene-based therapies.

Discover
Altar - entreprise génopolitaine - intégre le groupe Ginko Bioworks

Altar

Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover
Yposkesi - Genopole's Company

Yposkesi

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover
Watchfrog Laboratory - Genopole's company

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover
Pharming - Genopole's company - Logo 2021

PHARMING

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Discover
Global Bioenergies - entreprise génopolitaine - logo 2022

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

Discover
ABOLIS - entreprise génopolitaine

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

Discover
View all >
With the support from
Région île de France